IL6 and plasma cell myeloma: Consistently, IL-6 treatment significantly enhanced the growth of myeloma cells after 48-hour treatment with IL-6 in U266 cell line (Figure 1D) and 8226-cell line, in comparison with the treatment without IL-6 (p < 0.05) (Figure 1E).